Team-DellaAversana-C

• Personal statement
  

She is a young investigator at institute experimental endocrinology and oncology “Gaetano Salvatore”. She has a very brilliant university education and professional preparation gained over the years: I) degree in medical biotechnology at the University of Campania “LuigiVanvitelli”; vote:110/110 cum laude, plauso and dignity of press; II) PhD in Microbial Biotechnology and cell proliferation at the University of Messina vote:optimo;

III) Master II level in Cytogentics Interuniversity in Rome:TorVergata’s faculty of Medicine and Surgery; “Roma Tre” University; Faculty of Mathematical, Physical and Natural Sciences; “Casa sollievo della sofferenza” foundation; vote:96/100. IIII) Post doc at CNR-IGB and at Department of Precision Medicine of University of Campania “L.Vanvitelli”. During her career, she becames an indispensable and effective research collaborator in various work teams following different lines of research with marked autonomy and originality, intellectual and scientific,with an interdisciplinary,innovative and collaborative scientific approach with numerous universities and international and national research institutes (division of cancer medicine at MD Anderson Cancer Center; Department of Physics at University of Naples Federico II; exosomes research group at VU University Medical Center Amsterdam; Department of Pharmacy at University of Salerno; Universidad de Vigo; Department of Chemistry and Technology of drug at Sapienza University of Rome).

She stabilized a deep expertise in the field of translational cancer medicine.

• Starting from the molecular oncology, deciphering cellular dynamics and functional role of many epigenetic and post-translational mechanisms, mainly the orchestral regulation of non-coding rna, mirna.
• She explored the epigenetic drug discovery landscape, deepening the study of cancer arising from epigenetics, epigenetic enzymes as druggable targets and drug repurposing and repositioning to discovery new anticancer agents targeting epigenetics.
• In the last 4years, she investigated the molecular mechanism of extracellular vesicle-mediated cellular communication and therapeutics in cancer, mainly aml and neuroblastoma.

She combined in-depths studies in human (including various-omics methods), in vitro studies and in vivo models (mice). The excellent results obtained are the result of a fruitful activity of remarkable originality and diversified in multiple areas of avant-garde medicine, methodological accuracy and significant professional continuity.